search
Back to results

Does Caudal Block Increase the Incidence of Urethrocutaneous Fistula Formation Following Hypospadias Repair in Infants?

Primary Purpose

Hypospadias, Urethrocutaneous Fistula

Status
Active
Phase
Phase 4
Locations
United States
Study Type
Interventional
Intervention
Caudal block with ropivacaine
penile nerve block with bupivacaine
Sponsored by
University of Colorado, Denver
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Hypospadias focused on measuring hypospadias, caudal, urethrocutaneous fistula, penile nerve block

Eligibility Criteria

4 Months - 2 Years (Child)MaleDoes not accept healthy volunteers

Inclusion Criteria:

  • infants/ children with midshaft or distal hypospadias undergoing primary single stage repair in one of the Pediatric Regional Anesthesia Network participating centers.

Exclusion Criteria:

  • prior hypospadias surgery,
  • proximal or penoscrotal hypospadias,
  • abnormal caudal anatomy or spinal dysraphism,
  • cyanotic congenital heart disease,
  • infection or rash at the block injection site.

Sites / Locations

  • Children's Hospital Colorado

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Caudal block

Penile Nerve Block

Arm Description

Patients will receive a caudal block with 0.75-1ml/kg of 0.2% ropivacaine.

Patients will receive a dorsal penile nerve block with up to 0.75ml/kg of 0.25% bupivacaine.

Outcomes

Primary Outcome Measures

Incidence of urethrocutaneous fistula
Presence of a urethrocutaneous fistula at postoperative visit up to 1 year after surgery.

Secondary Outcome Measures

Degree of efficacy of caudal block
Blocks will be graded for efficacy using the following scale: Successful, Probably Successful, Probably Failed, or Failed.
Degree of pain
Patients will have pain scores determined using the modified FLACC score (Face, Legs, Activity, Cry, Consolability) 1 hour after arrival in the PACU
Need for supplemental analgesics
Administration of opioid in the first postoperative hour will be determined

Full Information

First Posted
June 21, 2016
Last Updated
January 23, 2023
Sponsor
University of Colorado, Denver
Collaborators
Stanford University, Dartmouth-Hitchcock Medical Center, Northwestern University, Boston Children's Hospital, Children's Medical Center Dallas, University of Mississippi Medical Center, University of New Mexico, The University of Texas Health Science Center, Houston, Oregon Health and Science University, Joe DiMaggio Children's Hospital, University of Michigan, Children's National Health System, University of Wisconsin, Madison, University of Iowa
search

1. Study Identification

Unique Protocol Identification Number
NCT02861950
Brief Title
Does Caudal Block Increase the Incidence of Urethrocutaneous Fistula Formation Following Hypospadias Repair in Infants?
Official Title
Does Caudal Block Increase the Incidence of Urethrocutaneous Fistula Formation Following Hypospadias Repair in Infants? A Multi-center Prospective Randomized Trial.
Study Type
Interventional

2. Study Status

Record Verification Date
January 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
May 24, 2017 (Actual)
Primary Completion Date
December 31, 2023 (Anticipated)
Study Completion Date
December 31, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Colorado, Denver
Collaborators
Stanford University, Dartmouth-Hitchcock Medical Center, Northwestern University, Boston Children's Hospital, Children's Medical Center Dallas, University of Mississippi Medical Center, University of New Mexico, The University of Texas Health Science Center, Houston, Oregon Health and Science University, Joe DiMaggio Children's Hospital, University of Michigan, Children's National Health System, University of Wisconsin, Madison, University of Iowa

4. Oversight

Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This is a prospective randomized multi-center non-inferiority trial conducted through the Pediatric Regional Anesthesia Network study sites to determine if caudal block increases the incidence of urethrocutaneous fistula following distal or mid shaft hypospadias repair compared with penile nerve block.
Detailed Description
Small retrospective series are in conflict about whether there is an association between caudal block and urethrocutaneous fistulas after hypospadias repair. The most common alternative to caudal blockade is a penile nerve block. The investigators will test the following hypothesis: There is no difference in the incidence of urethrocutaneous fistula formation following single stage hypospadias repair with caudal anesthesia compared with penile nerve block. The investigators will use a prospective randomized controlled design where subjects will receive either a caudal block or a penile nerve block to provide postoperative analgesia. Meatal anatomy will be graded by the urologist in the anesthetized child according to the HOPE (Hypospadias Objective Penile Evaluation) score, a validated scoring system. Both the total score and the individual component scores will be recorded. The operating urologist will determine the presence or absence of a fistula at the postoperative visit about 12 weeks after surgery, with subsequent follow up at 6 months and again at 12 months.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypospadias, Urethrocutaneous Fistula
Keywords
hypospadias, caudal, urethrocutaneous fistula, penile nerve block

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
490 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Caudal block
Arm Type
Active Comparator
Arm Description
Patients will receive a caudal block with 0.75-1ml/kg of 0.2% ropivacaine.
Arm Title
Penile Nerve Block
Arm Type
Active Comparator
Arm Description
Patients will receive a dorsal penile nerve block with up to 0.75ml/kg of 0.25% bupivacaine.
Intervention Type
Drug
Intervention Name(s)
Caudal block with ropivacaine
Intervention Description
Patients in this arm will receive a caudal block with ropivacaine
Intervention Type
Drug
Intervention Name(s)
penile nerve block with bupivacaine
Intervention Description
Patients in this arm will receive a penile block with bupivacaine
Primary Outcome Measure Information:
Title
Incidence of urethrocutaneous fistula
Description
Presence of a urethrocutaneous fistula at postoperative visit up to 1 year after surgery.
Time Frame
1 year
Secondary Outcome Measure Information:
Title
Degree of efficacy of caudal block
Description
Blocks will be graded for efficacy using the following scale: Successful, Probably Successful, Probably Failed, or Failed.
Time Frame
1 hour after arrival in Post Anesthesia Care Unit (PACU) post surgery
Title
Degree of pain
Description
Patients will have pain scores determined using the modified FLACC score (Face, Legs, Activity, Cry, Consolability) 1 hour after arrival in the PACU
Time Frame
1 hour after arrival in PACU post surgery
Title
Need for supplemental analgesics
Description
Administration of opioid in the first postoperative hour will be determined
Time Frame
1 hour after arrival in PACU post surgery

10. Eligibility

Sex
Male
Minimum Age & Unit of Time
4 Months
Maximum Age & Unit of Time
2 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: infants/ children with midshaft or distal hypospadias undergoing primary single stage repair in one of the Pediatric Regional Anesthesia Network participating centers. Exclusion Criteria: prior hypospadias surgery, proximal or penoscrotal hypospadias, abnormal caudal anatomy or spinal dysraphism, cyanotic congenital heart disease, infection or rash at the block injection site.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Megan Brockel, MD
Organizational Affiliation
University of Colorado, Denver
Official's Role
Principal Investigator
Facility Information:
Facility Name
Children's Hospital Colorado
City
Aurora
State/Province
Colorado
ZIP/Postal Code
80045
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Does Caudal Block Increase the Incidence of Urethrocutaneous Fistula Formation Following Hypospadias Repair in Infants?

We'll reach out to this number within 24 hrs